Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-15

Clinical Trial Update: Effectiveness of Biodentine v/s Calcium Hydroxide as Indirect Pulp Capping Materials [NA]

View source ↗

Summary

A completed clinical trial comparing Biodentine with calcium hydroxide as indirect pulp capping materials in patients with reversible pulpitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biodentine (tricalcium silicate cement)
  • Calcium hydroxide (calcium hydroxide)

Snippet

Sponsor: Zahoor khan | Conditions: Reversible Pulpitis | NA | Status: COMPLETED